Novel narrow spectrum kinase inhibitors inhibit rhinovirus replication via enhancement of interferon expression in nasal epithelial cells of atopic and non-atopic patients

M. Contoli, K. Ito, D. Poletti, A. Pastore, A. Papi (Ferrara, Italy; London, United Kingdom)

Source: Annual Congress 2011 - Insight into mechanisms of respiratory infections
Session: Insight into mechanisms of respiratory infections
Session type: Poster Discussion
Number: 3495
Disease area: Airway diseases, Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Contoli, K. Ito, D. Poletti, A. Pastore, A. Papi (Ferrara, Italy; London, United Kingdom). Novel narrow spectrum kinase inhibitors inhibit rhinovirus replication via enhancement of interferon expression in nasal epithelial cells of atopic and non-atopic patients. Eur Respir J 2011; 38: Suppl. 55, 3495

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
PUR1800 (RV1162), A novel narrow spectrum kinase inhibitor, but not Fluticasone, reduces TNFa-induced cytokine release by primary bronchial epithelial cells from healthy volunteers and COPD patients
Source: International Congress 2018 – Preclinical pharmacology: novel targets in airway inflammation, narrowing and neural control
Year: 2018



Inhibition of Pim1 kinase reduces viral replication in primary bronchial epithelial cells
Source: Eur Respir J 2015; 45: 1745-1748
Year: 2015


Syk is downstream of ICAM-1 and mediates human rhinovirus (HRV) activation of p38 MAP kinase in airway epithelial cells
Source: Annual Congress 2006 - Airway epithelial cells in inflammation
Year: 2006


Interferon-β response to rhinovirus infection in bronchial epithelial cells from asthmatic children
Source: Annual Congress 2009 - Epithelial cell biology
Year: 2009

Bronchial smooth muscle of severe asthmatic patients decreases rhinovirus replication within the epithelium through a CCL-20/PKR/eIF2-a dependent pathway
Source: Virtual Congress 2021 – Asthma treatment: clinical and translational science
Year: 2021



Studies into the mechanisms of deficient type I interferon production in asthmatic bronchial epithelial cells
Source: Annual Congress 2009 - Novel mechanisms in the pathogenesis of asthma
Year: 2009

Investigating the effects of interleukin-33 on rhinovirus A induced changes in asthmatic bronchial epithelial cells
Source: Virtual Congress 2020 – Novel molecular markers and targets for asthma phenotypes
Year: 2020


Rhinovirus triggers increased inflammasome activation in human bronchial epithelium in asthma.
Source: International Congress 2017 – Infection and exacerbation science
Year: 2017

The pan janus kinase (JAK) inhibitor KN-002 suppresses inflammatory mediator release from severe asthma bronchial epithelial cells.
Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science
Year: 2021


Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus
Source: Annual Congress 2005 - Environmental factors, allergy and asthma
Year: 2005


Protective effect of MAPK inhibitors and budesonide against apoptosis induced by TGF-β in primary cultures of human bronchial epithelial cells
Source: Eur Respir J 2003; 22: Suppl. 45, 394s
Year: 2003

The potent and lung-selective inhaled pan JAK inhibitor TD-8236 limits airway inflammation without affecting systemic immunity in mice
Source: International Congress 2019 – Novel targets and mechanisms in asthma
Year: 2019




Effects of respiratory syncytial virus and adenovirus infection in cytokine expression and nuclear factor-κB activation human bronchial epithelial cells
Source: Eur Respir J 2006; 28: Suppl. 50, 192s
Year: 2006

IL-33 may augment the effect of rhinovirus HRV16 on the inflammatory activity of human lung vascular endothelium – possible implication for asthma exacerbations.
Source: Virtual Congress 2021 – New insight into the immunology of allergies, asthma and COPD: from mouse to man
Year: 2021

TLR7/8 regulates type I and type III interferon signalling in rhinovirus 1b-induced allergic asthma
Source: Eur Respir J, 57 (5) 2001562; 10.1183/13993003.01562-2020
Year: 2021



The influence of allergen challenge on apoptosis and CD-95 receptor level in induced sputum cells from children with bronchial asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 6s
Year: 2002

Differential effect of fluticasone on Poly(I:C) induced TSLP secretion by bronchial epithelial cells from asthmatic children
Source: International Congress 2016 – Mechanisms of disease
Year: 2016

How cultured epithelial cells from asthma and COPD patients deal with pathogens: defective anti-rhinovirus responses in asthma
Source: Research Seminar 2008 - Host-pathogen interactions in the lung: implications for treatment of respiratory infections and inflammatory lung diseases
Year: 2008

Azithromycin augments rhinovirus-induced expression of IFNbeta and IFNλ1 in asthmatic bronchial epithelial cells by up-regulating RIG-I like receptors
Source: International Congress 2014 – Novel evidence relating to respiratory treatment development
Year: 2014

Rhinovirus up-regulates toll-like receptor 3 on bronchial epithelial cells and is dependent on viral replication
Source: Annual Congress 2004 - Mechanisms and treatment of virus induced asthma exacerbations
Year: 2004